Hudson Bay Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-235,000
| Closed | -$102K | – | 1091 |
|
2022
Q4 | $102K | Sell |
235,000
-1,445,536
| -86% | -$629K | ﹤0.01% | 711 |
|
2022
Q3 | $471K | Hold |
1,680,536
| – | – | ﹤0.01% | 859 |
|
2022
Q2 | $605K | Sell |
1,680,536
-1,464
| -0.1% | -$527 | ﹤0.01% | 923 |
|
2022
Q1 | $1.13M | Sell |
1,682,000
-118,000
| -7% | -$79.1K | 0.02% | 782 |
|
2021
Q4 | $2.32M | Buy |
1,800,000
+195,000
| +12% | +$252K | 0.02% | 625 |
|
2021
Q3 | $3.48M | Buy |
1,605,000
+65,000
| +4% | +$141K | 0.05% | 460 |
|
2021
Q2 | $4.2M | Sell |
1,540,000
-60,000
| -4% | -$164K | 0.05% | 390 |
|
2021
Q1 | $4.18M | Hold |
1,600,000
| – | – | 0.05% | 342 |
|
2020
Q4 | $4.45M | Buy |
1,600,000
+275,000
| +21% | +$765K | 0.05% | 244 |
|
2020
Q3 | $6.12M | Sell |
1,325,000
-350,000
| -21% | -$1.62M | 0.09% | 187 |
|
2020
Q2 | $4.72M | Buy |
1,675,000
+325,000
| +24% | +$916K | 0.08% | 194 |
|
2020
Q1 | $3.29M | Buy |
1,350,000
+756,784
| +128% | +$1.85M | 0.08% | 195 |
|
2019
Q4 | $3.04M | Buy |
593,216
+98,216
| +20% | +$503K | 0.07% | 221 |
|
2019
Q3 | $3.2M | Sell |
495,000
-55,000
| -10% | -$355K | 0.09% | 197 |
|
2019
Q2 | $3.43M | Buy |
550,000
+384,375
| +232% | +$2.4M | 0.08% | 197 |
|
2019
Q1 | $1.76M | Buy |
165,625
+9,375
| +6% | +$99.7K | 0.02% | 287 |
|
2018
Q4 | $1.25M | Buy |
156,250
+30,000
| +24% | +$239K | 0.02% | 330 |
|
2018
Q3 | $2.44M | Buy |
126,250
+29,762
| +31% | +$576K | 0.03% | 249 |
|
2018
Q2 | $1.74M | Buy |
96,488
+24,613
| +34% | +$445K | 0.02% | 302 |
|
2018
Q1 | $765K | Buy |
71,875
+28,125
| +64% | +$299K | 0.02% | 348 |
|
2017
Q4 | $1.85M | Buy |
+43,750
| New | +$1.85M | 0.04% | 229 |
|
2017
Q2 | – | Sell |
-3,125
| Closed | -$374K | – | 575 |
|
2017
Q1 | $374K | Buy |
+3,125
| New | +$374K | 0.01% | 358 |
|
2015
Q3 | – | Sell |
-2,500
| Closed | -$408K | – | 218 |
|
2015
Q2 | $408K | Buy |
+2,500
| New | +$408K | 0.01% | 133 |
|